CareDx, Inc. (CDNA) Guidance & Earnings Results
On 2026-07-30 CareDx, Inc. raised guidance: "FY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CDNACareDx, Inc.Follow CDNA — free
—
Price chart with a free account
- Market cap
- 3.6B
- P/E TTM
- 33.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 30 Jul 26 | Raised | FY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from $43-57M · full year |
| 24 Feb 26 | Raised | 2026 revenue $420M-$444M, adjusted EBITDA $30M-$45M · full year |
| 4 Nov 25 | Raised | Revenue guidance raised from $367-373M to $372-376M; EBITDA guidance raised from $29-33M to $35-39M. · full year |
| 6 Aug 25 | Raised | FY25 revenue raised to $367-373M from $365-375M; FY25 adjusted EBITDA unchanged at $29-33M · full year |
CareDx, Inc. — questions
- What guidance did CareDx, Inc. give?
- On 2026-07-30: "FY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from $43-57M"
- When does CareDx, Inc. report earnings?
- CareDx, Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from CareDx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.